GBA Presents: RADIO SAVANT-!
- Thread starter stonedinvestor
- Start date
Crowdstrike actually had a great report.
Upped guidance across the board. Nicely too.
Apparently the street wanted more upside than they provided.
Hmph.
That tells me tech is not out of the woods yet.
But after hours can be funny so... who knows. And the volume is a bit light. If it drops below $160 though, that may portend the nasdaq giving back today's gains, because I gotta think some buyers will step in and support it on any dips much below this level.
$168
Upped guidance across the board. Nicely too.
Apparently the street wanted more upside than they provided.
Hmph.
That tells me tech is not out of the woods yet.
But after hours can be funny so... who knows. And the volume is a bit light. If it drops below $160 though, that may portend the nasdaq giving back today's gains, because I gotta think some buyers will step in and support it on any dips much below this level.
$168
Are The Children of the 90's the the reason we are confused now?
Good AM-
RH Earn-!
non-GAAP EPS of $7.78 beats by $2.42, revenue of $957.29M beats by $32.53M
Jun. 02, 2022 4:14 PM ETRH (RH)
Good AM-
RH Earn-!
non-GAAP EPS of $7.78 beats by $2.42, revenue of $957.29M beats by $32.53M
Jun. 02, 2022 4:14 PM ETRH (RH)
- RHpress release(NYSE:RH): Q1 Non-GAAP EPS of $7.78beats by $2.42.
- Revenue of $957.29M (+11.2% Y/Y)beats by $32.53M.
- Shares-4%.
- Guidance: Second quarter net revenue growth expected to be in the range of (1%) to (3%), versus up 39% last year, with adjusted operating margin in the range of 23.0% to 23.5%, versus 26.6% a year ago.
- Fiscal 2022 net revenue growth in the range of 0% to 2%, versus up 32% last year, with adjusted operating margin in the range of 23.0% to 24.0%, versus 25.6% a year ago.
It's funny you don't hear the name Hess very much. Do you see any Hess stations? I believed the company may have gone away but no they are here and part of the only big oil discovery now.-
Offshore Guyana could contain billions more oil barrels, Hess CEO says
Jun. 02, 2022 6:55 PM ET Hess Corporation (HES),XOM
New oil findings at a deeper layer offshore Guyana could add billions of barrels to what is already the world's largest oil discovery in 20 years, Hess (NYSE:HES) CEO John Hess said Thursday, accordingto Reuters.
"There are multi-billion barrels remaining on top of" the 11B barrels of oil and gas found so far in the offshore Stabroek block, the CEO said, noting the Exxon-led (NYSE:XOM) consortium, which made most of its 30-plus oil discoveries at depths of ~15K feet, has started to drill at 18K feet.
The Fangtooth discovery well drilled earlier this year at 18K feet, for example, could underpin another production unit on its own, said Hess, whose company owns a 30% stake in the group.
The Guyana projects are ahead of schedule, and Exxon's (XOM) third planned platform may now start production at Payara as soon as Q3 2023, Hess told the Bernstein Strategic Decisions conference, adding that the Guyana gusher will exempt the company from needing to make acquisitions to sustain higher dividends to shareholders.
Lets Look Into HESS today.-
Offshore Guyana could contain billions more oil barrels, Hess CEO says
Jun. 02, 2022 6:55 PM ET Hess Corporation (HES),XOM
New oil findings at a deeper layer offshore Guyana could add billions of barrels to what is already the world's largest oil discovery in 20 years, Hess (NYSE:HES) CEO John Hess said Thursday, accordingto Reuters.
"There are multi-billion barrels remaining on top of" the 11B barrels of oil and gas found so far in the offshore Stabroek block, the CEO said, noting the Exxon-led (NYSE:XOM) consortium, which made most of its 30-plus oil discoveries at depths of ~15K feet, has started to drill at 18K feet.
The Fangtooth discovery well drilled earlier this year at 18K feet, for example, could underpin another production unit on its own, said Hess, whose company owns a 30% stake in the group.
The Guyana projects are ahead of schedule, and Exxon's (XOM) third planned platform may now start production at Payara as soon as Q3 2023, Hess told the Bernstein Strategic Decisions conference, adding that the Guyana gusher will exempt the company from needing to make acquisitions to sustain higher dividends to shareholders.
Lets Look Into HESS today.-
UPST IS BACK-
After its surprising move earlier in 2022 to park excess loans on its balance sheet, artificial intelligence-powered consumer lending platform Upstart (NASDAQ:UPST) has decided not to hold on to those loans, TheWall Street Journalreported.
Moreover, if the demand for loans dwindles, Upstart (UPST) would likely reduce its lending volume instead of parking those loans on its balance sheet, the company's CFO Sanjay Datta said, as reported by TheWSJ.
Datta added that Upstart (UPST) continues to hoard loans on its balance sheet in auto lending and other new business lines in an effort to "demonstrate to investors its ability to assess credit risk."
Note the company's lending platform aggregates consumer demand for loans and connects it to its network of AI-enabled bank partners. Upstart (UPST) charges a fee for that service, which is their primary way of generating revenue.
Pretty Big news...
After its surprising move earlier in 2022 to park excess loans on its balance sheet, artificial intelligence-powered consumer lending platform Upstart (NASDAQ:UPST) has decided not to hold on to those loans, TheWall Street Journalreported.
Moreover, if the demand for loans dwindles, Upstart (UPST) would likely reduce its lending volume instead of parking those loans on its balance sheet, the company's CFO Sanjay Datta said, as reported by TheWSJ.
Datta added that Upstart (UPST) continues to hoard loans on its balance sheet in auto lending and other new business lines in an effort to "demonstrate to investors its ability to assess credit risk."
Note the company's lending platform aggregates consumer demand for loans and connects it to its network of AI-enabled bank partners. Upstart (UPST) charges a fee for that service, which is their primary way of generating revenue.
Pretty Big news...
BIOTECH HAS BEEN IN A BEAR MARKET probably longer than Tech-
We almost had a break out when Pfizer bought someone... Well here we go again a major pharma paying UP!
The difference here with tech you get ripped off and the buyer gets this very low price in Bio if you have the goods they still give you the high price.
Bristol-Myers to acquire Turning Point Therapeutics for $76.00 per share 07:02 BMY, TPTX Bristol Myers Squibb…
Not bad for a $34 stock!
We almost had a break out when Pfizer bought someone... Well here we go again a major pharma paying UP!
The difference here with tech you get ripped off and the buyer gets this very low price in Bio if you have the goods they still give you the high price.
Bristol-Myers to acquire Turning Point Therapeutics for $76.00 per share 07:02 BMY, TPTX Bristol Myers Squibb…
Not bad for a $34 stock!
HEADS UP)
I want you all to benefit whenever possible. You can take advantage of my pain and misery if you buy IOVA. I freely admit I became attached to this stock. I can do that with biotech.
They had a mildly negative statistical read out and the stock was decimated. I have looked into the mater and feel there is still a pretty good chance for approval. I am sticking with this name and so is one frisky Director: Iovance Biotherapeutics director buys $6.6M in common stock 20:13 IOVA In a regulatory filing, Iovance Biotherapeutics disclosed that its director Wayne Rothbaum bought 1M shares of common stock on May 31st in a total transaction size of $6.6M.
That's freakin' $6+ mil bet-- you can bet $6K.
BUY 1000 IOVA AND LOOK AT IT NEXT YEAR. YOU WILL DOUBLE YOUR MONEY>
I want you all to benefit whenever possible. You can take advantage of my pain and misery if you buy IOVA. I freely admit I became attached to this stock. I can do that with biotech.
They had a mildly negative statistical read out and the stock was decimated. I have looked into the mater and feel there is still a pretty good chance for approval. I am sticking with this name and so is one frisky Director: Iovance Biotherapeutics director buys $6.6M in common stock 20:13 IOVA In a regulatory filing, Iovance Biotherapeutics disclosed that its director Wayne Rothbaum bought 1M shares of common stock on May 31st in a total transaction size of $6.6M.
That's freakin' $6+ mil bet-- you can bet $6K.
BUY 1000 IOVA AND LOOK AT IT NEXT YEAR. YOU WILL DOUBLE YOUR MONEY>
ADD COST TO THE LIST OF Earn calls!
Forgot that one.- Costco reports May sales of $18.23B, up 16.9% 16:23 COST Reports May comparable sales up 15.5%. Reports May e-commerce sales up 6.3%.
<<<< >>>>>
I have now looked through al accounts and no Snowflake.
Snowflake initiated with an Outperform at Raymond James 16:15 SNOW Raymond James analyst Simon Leopold initiated coverage of Snowflake with an Outperform rating and $184 price target. The company's differentiation in cloud data warehouse enables it to compete against cloud-agnostic and public cloud options, Leopold tells investors in a research note. The analyst sees Snowflake as a share gainer in a "massive" market with total addressable market expansion opportunities. He believes its sales can grow 50% annually over the next three years. However, with a lack of clear catalysts and an unfavorable market for growth stocks, Leopold refrains from a Strong Buy rating.
Forgot that one.- Costco reports May sales of $18.23B, up 16.9% 16:23 COST Reports May comparable sales up 15.5%. Reports May e-commerce sales up 6.3%.
<<<< >>>>>
I have now looked through al accounts and no Snowflake.
Snowflake initiated with an Outperform at Raymond James 16:15 SNOW Raymond James analyst Simon Leopold initiated coverage of Snowflake with an Outperform rating and $184 price target. The company's differentiation in cloud data warehouse enables it to compete against cloud-agnostic and public cloud options, Leopold tells investors in a research note. The analyst sees Snowflake as a share gainer in a "massive" market with total addressable market expansion opportunities. He believes its sales can grow 50% annually over the next three years. However, with a lack of clear catalysts and an unfavorable market for growth stocks, Leopold refrains from a Strong Buy rating.
Interesting upgrade here-
Stifel says Navigator's time 'has finally come,' raises price target to $19 13:51 NVGS Stifel analyst Benjamin Nolan raised the firm's price target on Navigator Holdings to $19 from $18, while keeping a Buy rating on the shares. The big picture for Navigator is that energy prices remain high, which should lead to increased supply from North America to satisfy increasing demand for oil and natural gas, the analyst notes. In the process of doing so, there will also be copious amounts of natural gas liquids, and their derivatives that far exceed domestic demand. The shipping of ethane and the derivatives in particular requires unique semi-refrigerated vessels, which is a niche market in which Navigator has a leading position, he adds. Market conditions are already tightening, and Nolan expects are likely to tighten further in coming years, with very limited ship supply growth. Consequently, the analyst believes Navigator's time has finally come, earnings and cash flows should grow consistently, and the share price should move higher.!! GOOD ONE!
STOCK OF THE DAY TO RESEARCH - NAVIGATOR NVGS
Stifel says Navigator's time 'has finally come,' raises price target to $19 13:51 NVGS Stifel analyst Benjamin Nolan raised the firm's price target on Navigator Holdings to $19 from $18, while keeping a Buy rating on the shares. The big picture for Navigator is that energy prices remain high, which should lead to increased supply from North America to satisfy increasing demand for oil and natural gas, the analyst notes. In the process of doing so, there will also be copious amounts of natural gas liquids, and their derivatives that far exceed domestic demand. The shipping of ethane and the derivatives in particular requires unique semi-refrigerated vessels, which is a niche market in which Navigator has a leading position, he adds. Market conditions are already tightening, and Nolan expects are likely to tighten further in coming years, with very limited ship supply growth. Consequently, the analyst believes Navigator's time has finally come, earnings and cash flows should grow consistently, and the share price should move higher.!! GOOD ONE!
STOCK OF THE DAY TO RESEARCH - NAVIGATOR NVGS